Eli Lilly's blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro posted weaker-than-expected sales for the ...
The Food and Drug Administration (FDA) recently removed Eli Lily's weight-loss drug from its shortage list ... brand names Mounjaro and Zepbound, is no longer in short supply, but it means ...
Analysts have struggled to estimate the size of the compounded market for weight-loss drugs because their sale is not tracked ...
The trial, which was funded by the drugs’ maker Eli Lilly, found that most ... to discontinue the drugs when their weight ...
Meanwhile, supply shortages of weight-loss drugs like Zepbound and Ozempic have led to a surge in knockoff "compounder" drugs ...
In essence, Viking could be in the early stages of developing a quadruple-pathway weight loss drug featuring the ... just yet ...
US drug shortages have decreased from 323 to 277 as of September 2024, yet many essential drugs remain scarce, with 50% of ...
In recent years, interest in these medications—initially developed to treat type 2 diabetes—has exploded, primarily because ...
Eli Lilly's ... weight loss drug Zepbound and diabetes treatment Mounjaro posted weaker-than-expected sales for the third quarter, even as both medicines have largely recovered from widespread ...